Timken Company (TKR)

$55.77 1.05 (1.85%)

19:00 EDT TKR Stock Quote Delayed 30 Minutes

Volume:

Previous Close $55.77

Market Cap 4.33B

PE Ratio 17.88

EPS 3.12

Volume (Avg. Vol.) 992,100

Day's Range 55.57 - 57.31

52-Week Range 22.25 - 58.78

Dividend & Yield 0.83 (1.49%)

TKR Stock Predictions, Articles, and Timken Company News

From InvestorPlace
From the Web

5 Industrial Services Stocks to Buy for a Recovery in 2020

By Stavros Georgiadis, CFA, InvestorPlace Contributor Aug 17, 2020

The industrial sector has underperformed the broader stock market, but that may have set these industrial services stocks up for success.

The 10 Best Cheap Stocks to Buy Right Now

By James Brumley, InvestorPlace Feature Writer Aug 20, 2019

Micron, Citigroup and General Motors are just some of the cheap stocks that investors may want to consider for their portfolio here.

U.S. Manufacturing Gathers Steam Under Trump: 5 Top Picks

By Zacks Investment Research Jun 14, 2018

Under Trump’s Presidency, the U.S. manufacturing sector has bolstered business spending at factories for expensive durable items such as machinery and veh....

5 Best Value Picks With a Tinge of Discounted PEG

By Zacks Investment Research Apr 12, 2018

While P/E alone fails to identify a true value stock, PEG helps to find the intrinsic value of a stock. Compare Brokers....

What Are The Best Penny Stocks To Buy Right Now? 4 Names To Know

From PennyStocks.com Sep 17, 2020

Are These On Your List Of Penny Stocks To Buy Or Avoid?

Aytu BioScience to Report Fourth Quarter FY 2020 Results and Business Update on Thursday, September 24, 2020

From Aytu BioScience, Inc. Sep 16, 2020

Live Conference Call and Webcast at 4:30 ET ENGLEWOOD, CO / ACCESSWIRE / September 16, 2020 / Aytu BioScience, Inc. (NASDAQ:AYTU) (the "Company"), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs, announced today that the Company will present its operational results for the fiscal fourth quarter ended June 30, 2020 on September 24, 2020, at 4:30 p.m. ET. The Company

Looking For Top Penny Stocks To Buy Today? 4 To Watch Closely

From PennyStocks.com Sep 14, 2020

Decide If These Top Penny Stocks Are A Buy Or Sell Today

Looking For Penny Stocks To Buy After Gilead & Immunomedics’ $21B Deal? 4 To Watch

From PennyStocks.com Sep 13, 2020

Are Biotech Penny Stocks On Your List After Gilead & Immunomedics Ink A $21B Deal?

Aytu Bio inks deal to distribute Pinnacle IVD's COVID-19 rapid antigen test (NASDAQ:AYTU)

From Seeking Alpha Sep 8, 2020

Aytu BioScience (NASDAQ:AYTU) has signed an agreement to distribute the Pinnacle CovID RAD Rapid Antigen Detection Test worldwide.The rapid antigen test, which delivers results in 15 minutes, tests for the presence of the SARS-CoV-2 virus antigen via a nasopharyngeal sample.

Aytu BioScience Announces Global Agreement to Distribute Pinnacle IVD Corporation's 15-Minute COVID-19 Antigen Test

From Aytu BioScience, Inc. Sep 8, 2020

Pinnacle Plans to Scale U.S. Manufacturing Capacity to 25 Million Tests Per Month Cost-Effective 15-Minute Rapid Antigen Test Demonstrates 100% Specificity for COVID-19 Detection When Compared with RT-PCR ENGLEWOOD, CO / ACCESSWIRE / September 8, 2020 / Aytu BioScience, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company (the "Company") focused on commercializing novel products that address significant patient needs

Navellier Ratings

Powered by Portfolio Grader

Total Grade

B

Buy